Develop modeling framework to use in understanding the impact of certain policy and marketing authorization decisions on population health. Two models are presently in development to address: (1) the relative impact of policies on tobacco-related opinions and behavior over the short-term (such as initiation and cessation rates); and (2) the long-term impact on tobacco use prevalence, morbidity, and mortality in the U.S. <i>Information current as of November 30, 2012</i>Milestones with N/A were completed prior to the project incorporation into FDA-TRACK.ON TRACKON TRACK1. Implement an Interagency Agreement with the Department of Energy/Sandia National LaboratoriesN/ACompletedN/A2. Develop preliminary modeling framework that incorporates initiation, cessation, and smoking-related mortalityN/ACompletedN/A3. Conduct meeting with representatives from CTP, CDC, and Sandia to provide input and feedbackN/ACompletedN/A4. Produce preliminary report demonstrating model capabilities and examining hypothetical scenarios8/1/2011Completed8/1/20115. Present method development and preliminary findings to CTP during in person visit12/14/2011Completed12/14/20116. Produce report/presentation of results after expansion and refinement to take into account racial/ethnic diversity, multiple tobacco products; and multiple causes of death5/30/2013On Track7. Submit modeling methodology for publication in peer-reviewed journal5/30/2013On Trackhttp://www.fda.gov/AboutFDA/Transparency/track/ucm252849.htmFDA-TRACK CTP Dashboard਍††਍਍਍਍਍਍਍